# Fulphila

NDC: 83257-005
Generic name: pegfilgrastim-jmdb
Labeler / Manufacturer: Biocon Biologics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20231001

FDA application: BLA761075

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83257-005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83257-005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bfc4d3e-6120-7fec-f1d6-0b3743752034